COMPANIES COVERED
Abbott DiagnosticsDownload FREE Report Sample
Download Free sampleRenal biomarkers help diagnose or identify the patients at risk of developing kidney diseases, by measuring their blood or urine levels. They are commonly released in acute or chronic kidney injuries, which are characterized by the rapid or gradual loss of kidney function resulting into serous clinical implications.
Renal Biomarkers Market contains market size and forecasts of Renal Biomarkers in Global, including the following market information:
Global Renal Biomarkers Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Renal Biomarkers market was valued at 1202.5 million in 2021 and is projected to reach US$ 1657.2 million by 2028, at a CAGR of 4.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Enzyme Linked Immunosorbent Assay (ELISA) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Renal Biomarkers include Abbott Diagnostics, F. Hoffmann-La Roche, Beckman Coulter, Siemens Healthcare Diagnostics, Thermo Fisher Scientific, Astute Medical, BioMerieux SA and Randox Laboratories, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Renal Biomarkers companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Renal Biomarkers Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Renal Biomarkers Market Segment Percentages, by Type, 2021 (%)
Enzyme Linked Immunosorbent Assay (ELISA)
Enzymatic Assay
Turbidimetric Immunoassay
Others
Global Renal Biomarkers Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Renal Biomarkers Market Segment Percentages, by Application, 2021 (%)
Diagnosis and Disease Progression Monitoring
Research
Others
Global Renal Biomarkers Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Renal Biomarkers Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Renal Biomarkers revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Renal Biomarkers revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Diagnostics
F. Hoffmann-La Roche
Beckman Coulter
Siemens Healthcare Diagnostics
Thermo Fisher Scientific
Astute Medical
BioMerieux SA
Randox Laboratories
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
